Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Hypoactive Sexual Desire Disorder
Interventions: DRUG: testosterone gel|DRUG: placebo gel
Sponsor: BioSante Pharmaceuticals